ACTRN12623000038695招募中未知
A Proof Of Concept study to evaluate the sensitivity and specificity of Wearables and Algorithm Technology for Chronic Heart Disease in the diagnosis of Heart Failure.
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •1. 18-75 years of age.
- •2. Diagnosed with Heart Failure (New York Heart Association (NYHA) II to IV) for RHC as part of standard medical care.
排除标准
- •1. Participant is on mechanical ventilation.
- •2. Participant is receiving cardiac mechanical support.
- •3. Participant is pregnant or lactating.
- •4. Inability to place morphic sensors.
- •5. Participating in a concurrent clinical investigation which has not yet met its primary endpoint, or in the investigator’s opinion, participation in this study would affect the primary endpoint of the concurrent study.
研究者
相似试验
尚未招募
不适用
A Proof Of Concept study to evaluate the sensitivity and specificity of Wearable and Artificial Intelligence Technology for Chronic Heart Disease used in detecting irregular heart rhythm of patients with Atrial Fibrillation, The POC WATCH AF” studyCardiac arrhythmiaCardiovascular - Coronary heart diseaseAtrial FibrillationACTRN12621000849897Medical Monitoring Solutions Pty Ltd30
进行中（未招募）
1 期
Clinical pilot study for evaluation of the effect of ketamine intranasal spray in treatment of chronic Cluster HeadacheChronic Cluster HeadacheMedDRA version: 20.0Level: PTClassification code 10059133Term: Cluster headacheSystem Organ Class: 10029205 - Nervous system disordersEUCTR2019-001260-29-DKCCH Pharmaceuticals20
进行中（未招募）
不适用
Proof of concept study to investigate the impact of BAY 58-2667 given intravenously in patients with acute decompensated chronic congestive heart failureEUCTR2005-004473-14-DEBayer HealthCare AG60
已完成
不适用
How well does the plastic detection comb (PDC) remove nits?ISRCTN72989363KSL Consulting (Denmark)25
已完成
2 期
A prospective *proof of concept study* to evaluate the potential efficacy of ustekinumab in patients with moderate to severe hidradenitis suppurativa (acne ectopica)acne ectopicaacne inversa10040798hidradenitis suppurativaNL-OMON37989niversitair Medisch Centrum Groningen20